Boston Scientific Corporation (FRA:BSX)
90.40
+1.40 (1.57%)
Jun 6, 2025, 6:11 PM CET
Boston Scientific Revenue
Boston Scientific had revenue of $4.66B USD in the quarter ending March 31, 2025, with 20.93% growth. This brings the company's revenue in the last twelve months to $17.55B, up 19.36% year-over-year. In the year 2024, Boston Scientific had annual revenue of $16.75B with 17.61% growth.
Revenue (ttm)
$17.55B
Revenue Growth
+19.36%
P/S Ratio
8.17
Revenue / Employee
$331.21K
Employees
53,000
Market Cap
132.63B EUR
Revenue Chart
* This company reports financials in USD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 16.75B | 2.51B | 17.61% |
Dec 31, 2023 | 14.24B | 1.56B | 12.29% |
Dec 31, 2022 | 12.68B | 794.00M | 6.68% |
Dec 31, 2021 | 11.89B | 1.98B | 19.92% |
Dec 31, 2020 | 9.91B | -822.00M | -7.66% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Siemens Healthineers AG | 23.14B |
Merck KGaA | 21.32B |
Bayer Aktiengesellschaft | 46.58B |
Fresenius SE & Co. KGaA | 22.13B |
Fresenius Medical Care AG | 19.49B |
Sartorius Aktiengesellschaft | 3.44B |
Carl Zeiss Meditec AG | 2.17B |
Fielmann Group AG | 2.33B |
Boston Scientific News
- 3 days ago - Is Boston Scientific Gaining or Losing Market Support? - Benzinga
- 8 days ago - P/E Ratio Insights for Boston Scientific - Benzinga
- 8 days ago - Boston Scientific: Old, Reliable; Buy For Their Consistent Growth - Seeking Alpha
- 9 days ago - Michael Mahoney Turned Boston Scientific Into A Medical Tech Empire - Investor's Business Daily
- 10 days ago - Boston Scientific Scraps This Aortic Valve, Sticks To 2025 Outlook - Benzinga
- 10 days ago - Boston Scientific Scraps This Aortic Valve, Sticks To 2025 Outlook - Benzinga
- 10 days ago - Boston Scientific Corporation (BSX) Bernstein 41st Annual Strategic Decisions Conference (Transcript) - Seeking Alpha
- 10 days ago - How Boston Scientific's Surprise Setback Bolstered Edwards, Medtronic, Abbott - Investor's Business Daily